← All workflows

Biotech Patent Summaries

Biotech Patent Intelligence Briefs in Minutes

12 minutes with CaseMark

Fast lane

We have it from here.

Choose the fast one-off run here, or jump into the workspace when you want saved history, revisions, and a fuller matter workflow.

Run this once here

Best for a quick one-off job. Add your email, upload the files, and we'll run the workflow and send the result to your inbox.

1. Add your email so we know where to send the result.

2. Upload the files you want analyzed.

3. Run the workflow and we'll take it from there.

Use in Workspace

Best for ongoing matters

Save and reopen matters, keep documents together, refine the output, rerun with changes, and export or share polished work product when you're done.

Open in Workspace

Need more context?

Scroll for the workflow details below if you want to review what this run handles, what documents help, and what the output looks like.

If this is part of a live matter, the workspace is the better fit: you can keep your documents together, revisit the result, and keep working without starting from scratch.

Jump to detailsOpen in Workspace

Start here

Run this workflow now

Best for a fast one-off run. Add your email, upload the files, and we'll deliver the result without sending you into the full app.

Workflow

Biotech Patent Summaries

Step 1 · Deliver to

Step 3 · Run this workflow

Workflow

Biotech Patent Summaries

Overview

CaseMark's Biotech Patent Summaries skill transforms complex patent portfolios and dispute materials into structured, litigation-ready intelligence briefs. The AI extracts and maps claims, analyzes validity and enforceability, and quantifies litigation risk—all with source-grounded confidence tagging. Purpose-built for the unique challenges of biotechnology IP, it handles everything from genus claims over biological matter to §101 eligibility questions for diagnostics and natural products.

Biotech patent analysis is among the most time-intensive tasks in IP litigation. Attorneys must manually parse dense prosecution histories, map complex claim hierarchies covering biological mechanisms and molecules, and synthesize multi-jurisdictional dispute postures—often under tight litigation deadlines. A single patent family can consume dozens of billable hours before a coherent strategic picture emerges.

CaseMark automates the heavy lifting of biotech patent analysis by ingesting entire patent corpora, extracting and mapping claim sets, and running systematic validity and infringement assessments. The result is a structured intelligence brief with every assertion tagged by confidence level and source, ready for litigation strategy sessions, portfolio decisions, or executive briefings in a fraction of the traditional time.

How it works

  1. 1. Upload your biotech patent documents, prosecution histories, and dispute materials

  2. 2. AI ingests, normalizes, and maps patent claims, families, and dispute metadata

  3. 3. Review the structured intelligence brief with confidence-tagged assertions

  4. 4. Export your litigation-ready brief in your preferred format (DOCX, PDF)

What you get

  • Patent Identity & Family Overview

  • Technical Scope & Mechanism Summary

  • Claim Set Extraction & Mapping

  • Validity & Enforceability Analysis

  • Litigation Risk & Procedural Assessment

  • Strategic Recommendations & Commercial Impact

What it handles

  • Automated claim extraction and mapping of independent and dependent claims with verbatim critical language

  • Validity and enforceability analysis across §101 eligibility, §102/103 novelty, and §112 enablement

  • Litigation risk quantification including injunction exposure, claim-construction volatility, and timeline assessment

  • Cross-jurisdiction analysis covering procedural differences and commercial impact

  • Source-grounded confidence tagging distinguishing confirmed facts from party arguments and analytical assessments

  • Patent family mapping with normalized dates, assignee tracking, and prosecution history synthesis

Required documents

  • Patent Documents

    Patent applications, issued patents, and associated prosecution histories for the biotech patent family under analysis

    .pdf, .docx

  • Dispute & Litigation Materials

    PTAB filings, court documents, complaints, claim construction briefs, or other litigation materials related to the patent dispute

    .pdf, .docx

Supporting documents

  • Licensing Agreements

    Existing licensing agreements, term sheets, or royalty schedules relevant to the patent portfolio

    .pdf, .docx

  • Prior Art References

    Prior art publications, patents, or scientific literature cited during prosecution or identified for invalidity arguments

    .pdf, .docx

  • Product Technical Documentation

    Technical specifications, product descriptions, or process documentation for accused or at-risk products

    .pdf, .docx

Why teams use it

Reduce patent analysis time from days to minutes while maintaining litigation-grade rigor and source traceability

Gain structured claim maps with verbatim language extraction, enabling faster claim construction preparation and infringement assessment

Identify validity vulnerabilities and enforceability risks across §101, §102/103, and §112 with systematic, repeatable analysis

Deliver executive-ready intelligence briefs with clear confidence tagging that distinguishes facts from arguments and analytical conclusions

Questions

What types of biotech patent documents can CaseMark analyze?

CaseMark processes patent applications, issued patents, PTAB filings, prosecution histories, licensing agreements, and litigation documents across all biotechnology domains. The AI handles complex biological subject matter including diagnostics, therapeutics, gene editing, and biologics platforms.

How does CaseMark handle patent validity analysis?

CaseMark systematically evaluates enforceability across key vectors including §101 eligibility for methods and natural products, §102/103 novelty and obviousness, and §112 enablement and written description issues. Each analytical assertion is tagged with a confidence level so you can quickly assess reliability.

Can CaseMark perform freedom-to-operate (FTO) analysis?

Yes, CaseMark generates FTO-oriented intelligence briefs by mapping patent claims against accused products or processes, identifying potential infringement risks, and highlighting design-around opportunities. The output is structured for immediate use in strategic decision-making.

How does CaseMark ensure accuracy in its patent summaries?

CaseMark is source-grounded, meaning every assertion in the intelligence brief is tied back to specific documents you provide. The system tags each item as a confirmed fact, party argument, or analytical assessment, giving you full transparency into the basis for every conclusion.

Can I use CaseMark for multi-jurisdiction patent disputes?

Absolutely. CaseMark analyzes cross-jurisdiction differences in patent enforcement, procedural requirements, and commercial consequences. The intelligence brief highlights jurisdiction-specific risks and strategic considerations for global biotech patent portfolios.

How long does it take to generate a biotech patent intelligence brief?

CaseMark typically generates a comprehensive intelligence brief in approximately 12 minutes, depending on the volume and complexity of the patent documents provided. This replaces what traditionally takes days or weeks of manual attorney review.

Related

30b6 Corporate Rep

Master 30(b)(6) Depositions in Minutes, Not Hours

30b6 Deposition

Draft & Defend 30(b)(6) Depositions in Minutes

Abstract of Judgment

Draft Judgment Abstracts in Minutes, Not Hours